Wasatch Advisors Inc Bria Cell Therapeutics Corp. Transaction History

Wasatch Advisors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$5.72 - $7.58 $22,822 - $30,244	-3,990 Reduced 0.65%	612,088 $3.93 Million
Q1 2023 May 12, 2023	BUY	$4.59 - $7.99 $961,458 - $1.67 Million	209,468 Added 51.52%	616,078 $4.59 Million
Q4 2022 Feb 14, 2023	BUY	$4.28 - $6.73 $226,266 - $355,788	52,866 Added 14.94%	406,610 $1.78 Million
Q3 2022 Nov 14, 2022	SELL	$3.0 - $8.31 $8,262 - $22,885	-2,754 Reduced 0.77%	353,744 $1.99 Million
Q2 2022 Aug 12, 2022	BUY	$4.28 - $11.9 $478,533 - $1.33 Million	111,807 Added 45.69%	356,498 $2.06 Million
Q1 2022 May 13, 2022	BUY	$5.91 - $10.14 $1.45 Million - $2.48 Million	244,691 New	244,691 $2.48 Million

Ticker BCTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,518,000
Market Cap $5.9M
Description
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Wasatch Advisors Inc with notifications on news.